Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.062,83
0,09%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ uniQure NV (QURE) uniQure NV (QURE) Notizie

uniQure NV

QURE
4,98
-0,27 (-5,14%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202413:18EDGAR2Form 8-K - Current report
03/6/202413:05GLOBEuniQure Receives FDA Regenerative Medicine Advanced Therapy..
07/5/202414:03EDGAR2Form 8-K - Current report
07/5/202413:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:05GLOBEuniQure Announces First Quarter 2024 Financial Results and..
05/3/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202414:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202414:00EDGAR2Form 8-K - Current report
28/2/202413:05GLOBEuniQure Announces 2023 Financial Results and Highlights..
26/2/202422:46EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:25EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/12/202313:12EDGAR2Form 8-K - Current report
19/12/202313:05GLOBEuniQure Announces Update on Phase I/II Clinical Trials of..
12/12/202301:30PRNUSCSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb)..
08/12/202313:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
29/11/202313:05GLOBEuniQure Announces FDA Clearance of Investigational New Drug..
17/11/202312:00EDGAR2Form 8-K - Current report
07/11/202313:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:31EDGAR2Form 8-K - Current report
07/11/202313:05GLOBEuniQure Announces Third Quarter 2023 Financial Results and..
27/10/202316:00PRNUSCSL and uniQure Win 2023 Prix Galien USA Award
26/10/202320:38PRNCASanté Canada autorise HEMGENIX® de CSL (étranacogène..
26/10/202320:14PRNCAHealth Canada Authorizes CSL's HEMGENIX® (etranacogene..
24/10/202313:05GLOBEuniQure Announces Major Presence at the European Society of..
06/10/202312:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/10/202312:32EDGAR2Form DEF 14A - Other definitive proxy statements
05/10/202322:32EDGAR2Form 8-K - Current report
05/10/202313:05GLOBEuniQure Announces Strategic Reorganization to Reduce..
03/10/202303:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202313:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
20/9/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202319:59DJNRe/Max, UniQure and Trinseo Fall to 52-Week Lows on Exit..
05/9/202313:05GLOBEuniQure Announces FDA Clearance of Investigational New Drug..
02/9/202300:51PRNUSBlackstone and Airbnb Set to Join S&P 500; Others to Join..
01/8/202322:30EDGAR2Form 8-K - Current report
01/8/202313:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202313:05GLOBEuniQure Announces Second Quarter 2023 Financial Results and..
12/7/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202316:58EDGAR2Form 144 - Report of proposed sale of securities
26/6/202313:11GLOBEuniQure Announces Leadership Addition to Support Advancement..
21/6/202313:05GLOBEuniQure Announces Update on U.S. Phase I/II Clinical Trial..
20/6/202313:05GLOBEuniQure announces achievement of $100 million..
20/6/202313:00PRNUSCSL Behring Announces the First Patient Has Received..
16/6/202313:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
Apertura: 5,20 Min: 4,86 Max: 5,22
Chiusura: 5,25

La tua Cronologia

NASDAQ
QURE
uniQure NV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network